- Zipes D.P.
- Link M.S.
- Ackerman M.J.
- Kovacs R.J.
- Myerburg R.J.
- Estes III, N.A.
- Heidbuchel H.
- Arbelo E.
- D’Ascenzi F.
- et al.
- Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2015; 66: 2412-2423
- Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators.Europace. 2021; 23: 147-148
- 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.Eur Heart J. 2021; 42: 17-96
- Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes.J Am Coll Cardiol. 2002; 40: 446-452
- Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.Eur Heart J. 2010; 31: 806-814
- Ventricular arrhythmias in athletes: role of a comprehensive diagnostic workup.Heart Rhythm. 2022; 19: 90-99
- Return-to-play for athletes with long QT syndrome or genetic heart diseases predisposing to sudden death.J Am Coll Cardiol. 2021; 78: 594-604
Funding Sources: The author has no funding sources to disclose.
Disclosures: Dr Heidbuchel has been a member of the scientific advisory boards of and/or a lecturer for Biotronik, Daiichi Sankyo, Pfizer-Bristol Myers Squibb, Springer Healthcare and has received unconditional research grants through the University of Antwerp and/or the University of Hasselt from Bracco Imaging Europe, Daiichi Sankyo, Boehringer Ingelheim, Abbott, Medtronic, Biotronik, St. Jude Medical, and FibriCheck/Qompium.